Healthcare
China develops AI to help diagnose rare diseases
CSL and Peking Union Medical College Hospital announced cooperation on AI tools intended to help diagnose rare diseases in China.
China’s CSL announced cooperation with Peking Union Medical College Hospital in Beijing to develop AI capabilities for diagnosing rare diseases. The announcement was made during the China International Import Expo in Shanghai, held from November 5 to 10, 2026. The collaboration focuses on applying artificial intelligence to a clinical area where diagnosis can be difficult because rare diseases often involve limited case data and complex symptom patterns. Peking Union Medical College Hospital is involved as the clinical institution in the reported cooperation, while CSL is identified as the collaborating organization. The project demonstrates how hospitals and technology or life-sciences companies are pursuing specialized AI tools rather than only broad administrative automation. Rare-disease diagnosis is a practical healthcare application because machine-learning systems can support clinicians in recognizing patterns and prioritizing possible conditions. The source does not provide performance results, deployment dates, or details on regulatory approval.
Original source: VOI